## Background: Patients with longstanding quiescent crohn's disease on azathioprine usually maintain an excellent quality of life but are also concerned about long-term safety. this may affect adherence to treatment. the aim of the present study was to assess the adherence to azathioprine in a coho
MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn's disease
✍ Scribed by Juan L. Mendoza; Elena Urcelay; Raquel Lana; M. Carmen Martín; Natalia López; Luis G. Guijarro; Julio A Mayol; Carlos Taxonera; Emilio G. de la Concha; Amado S. Peña; Manuel Díaz-Rubio
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 91 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
✦ Synopsis
Background:
To investigate the contribution of multidrug resistance 1 (MDR1) gene pharmacogenetics (G2677T/A and C3435T) to the efficacy of azathioprine in inducing remission in patients with Crohn's disease (CD).
Methods:
A cohort of 327 unrelated Spanish patients with CD recruited from a single center was studied. All patients were rigorously followed up for at least 2 years (mean time, 11.5 years). A case-control analysis of MDR1 G2677T/A and C3435T SNPs and 2 loci haplotypes in 112 steroid-dependent CD patients treated with azathioprine was performed. Patients were classified on the basis of response to azathioprine.
📜 SIMILAR VOLUMES
Background: Corticosteroids (CS) effectively induce remission in patients with moderate to severe Crohn's disease (CD). However, CS dependence in children is a significant clinical problem associated with numerous side effects. Identification of molecular markers of CS dependence is of paramount imp